Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling.
Sabrina J RitchBreeAnn N BrandhagenAlicia A GoyenecheCarlos M TelleriaPublished in: BMC cancer (2019)
This study reports that antiprogestin mifepristone inhibits migration and invasion of highly metastatic cancer cell lines, and that double fluorescence cytochemical labeling increases the value of well-known approaches to study cell movement.